Brad Greenspan, former founder of Intermix Media, has made a seed investment in a Michigan-based firm focused on manufacturing of components for the anti-influenza drug Tamiflu. Greenspan, known for his public scuffle over Intermix's acquisition by News Corp, said that he was investing $1M in Draths, which is also receiving SBIR funding. Greenspan was ousted as CEO of Intermix in 2003.
Top NewsWednesday, April 19, 2006
Greenspan Makes Angel Investment In Michigan